 PITTSBURGH, Sept. 08, 2022 GLOBE NEWSWIRE -- Krystal Biotech, Inc. the Company NASDAQ: KRYS, the leader in redosable gene therapy, announced today that the Company will participate in the H.C. Wainwright 24th Annual Global Investment Conference in New York from September 12-14. 